Skin Ulcers

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2012-08-15
EMA Withdrawn: Regranex (becaplermin) — Janssen-Cilag International NV
The EMA withdrew Regranex (becaplermin) from the market for wound healing and skin ulcers at Janssen-Cilag International NV on 11/10/2010.